| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Warner TG | |
| P2860 | cites work | Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts | Q42815554 |
| P433 | issue | 9 | |
| P304 | page(s) | 841-850 | |
| P577 | publication date | 1999-09-01 | |
| P1433 | published in | Glycobiology | Q5572596 |
| P1476 | title | Enhancing therapeutic glycoprotein production in Chinese hamster ovary cells by metabolic engineering endogenous gene control with antisense DNA and gene targeting | |
| P478 | volume | 9 |
| Q35940952 | Advances in the production of human therapeutic proteins in yeasts and filamentous fungi |
| Q30462030 | Cell cycle phase dependent productivity of a recombinant Chinese hamster ovary cell line |
| Q43555039 | Characterization of cytosolic sialidase from Chinese hamster ovary cells: part I: cloning and expression of soluble sialidase in Escherichia coli |
| Q35820079 | Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression |
| Q33661333 | Engineering host cell lines to reduce terminal sialylation of secreted antibodies |
| Q38302483 | Exploring the acceptor substrate recognition of the human beta-galactoside alpha 2,6-sialyltransferase |
| Q43660922 | Generation and comparative characterization of glycosylated and aglycosylated human IgG1 antibodies |
| Q34660107 | Inverse metabolic engineering to improve Escherichia coli as an N-glycosylation host. |
| Q35550669 | Metabolic Engineering: Advances in Modeling and Intervention in Health and Disease |
| Q38099382 | New developments in lentiviral vector design, production and purification |
| Q51758211 | Poly-γ-glutamic acid enhances the growth and viability of Chinese hamster ovary cells in serum-free medium. |
| Q35613487 | Poly-γ-glutamic acid enhances the quality of recombant erythropoietin produced by CHO cells |
| Q35225062 | Reduction in C-terminal amidated species of recombinant monoclonal antibodies by genetic modification of CHO cells |
| Q44525679 | Reduction of CMP-N-acetylneuraminic acid hydroxylase activity in engineered Chinese hamster ovary cells using an antisense-RNA strategy |
| Q24814865 | Reproducible doxycycline-inducible transgene expression at specific loci generated by Cre-recombinase mediated cassette exchange |
| Q40360628 | Selection of highly productive mammalian cells based on an inducible growth advantage using an antibody/receptor chimera. |
| Q36327788 | Stable plastid transformation for high-level recombinant protein expression: promises and challenges. |
| Q38209626 | The biotechnological potential of fibrinolytic enzymes in the dissolution of endogenous blood thrombi |
| Q48072556 | The growth hormone-encoding gene isolated and characterized from Labeo rohita Hamilton is expressed in CHO cells under the control of constitutive promoters in 'autotransgene' constructs |
| Q37323557 | Using cell engineering and omic tools for the improvement of cell culture processes |
| Q38055447 | With or without sugar? (A)glycosylation of therapeutic antibodies |
Search more.